Global contract research organisation Syngene International Limited announced the resignation of Dr. Joydeep Kant as Senior Vice President – Development Services of the company, with effect from October 31, 2023. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), this is to inform…
Syngene International has appointed Joydeep Kant as SVP of Development Services and Andrew Webster as Chief Human Resources Officer. Joydeep Kant joined the Company in November 2022 as SVP Development Services and a member of the Executive Committee. Joydeep is an organic chemist with a Ph.D. from the University of Missouri (USA) and postdoctoral training…
Cyril Amarchand Mangaldas advised Biocon Limited (Biocon), in relation to the sale of shares by Biocon Limited in Syngene International Limited (Syngene International), by way of a bulk trade on the stock exchanges, aggregating to INR 1220.28 crores. The Capital Market Practice of Cyril Amarchand Mangaldas advised Biocon for the transaction and assisted with, reviewing, and finalizing the transaction…
Syngene International Limited, an integrated research, development and manufacturing services company, announced the re-appointment of Sharmila Abhay Karve as Independent Director on the company’s Board, with effect from July 20, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you…
Syngene International Limited, an integrated research, development and manufacturing organisation, announced the appointment of Dr Carl Decicco as Additional Director of the company, effective March 1, 2022. According to the company’s exchange filing, “It is further informed that the Board of Directors has approved the appointment of Dr Carl Decicco as Additional Director (Non-executive Non-independent)…